NCT03018002

Brief Summary

The purpose of this study is to evaluate the comparative effectiveness of a congregation, clinic and integrated case management-based intervention for sustainable testing and retention on linkage to care, engagement, retention and viral load suppression of women and children infected with HIV.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P50-P75 for not_applicable hiv

Timeline
Completed

Started Jul 2016

Typical duration for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

January 6, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 11, 2017

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

January 11, 2017

Status Verified

January 1, 2017

Enrollment Period

3.7 years

First QC Date

January 6, 2017

Last Update Submit

January 10, 2017

Conditions

Keywords

HIV, PMTCT

Outcome Measures

Primary Outcomes (2)

  • Linkage in care

    Linkage in care is defined as the percentage of participants with at least one HIV medical care visit following HIV diagnosis.

    1 month

  • Retention in care

    Retention is defined as the percentages of participants with two or more documented viral load measurement during the 12 months following enrollment.

    12 months

Secondary Outcomes (2)

  • ART Initiation

    1 month

  • Viral Suppression

    12 months

Study Arms (2)

Control group

NO INTERVENTION

HIV-infected participants identified from the churches randomized to CG will be referred to PEPFAR-supported HIV clinics that provide comprehensive care including counseling, laboratory testing, ART and ongoing support during treatment as the standard of care. The study team will not be involved in their care beyond data collection.

iSTAR

EXPERIMENTAL

HIV-infected participants identified from the churches clustered within the randomized health facilities will receive interventions from the study team.

Other: iSTAR

Interventions

iSTAROTHER

Each component of the iSTAR intervention targets a specific point along the HIV continuum: confidential, onsite integrated laboratory tests during baby showers targets HIV diagnosis (b) church-based Health Advisors (CHAs) trained in motivational interviewing and quality improvement skills as promotoras target linkage, engagement and adherence by providing counseling and other support to HIV-infected women and children (c) integrated network of community and clinic case management targets reduction in loss to follow-up. CHAs will support participants during the study period by being available to accompany them to clinic visits, review laboratory results and medications after clinic visits. They will be available to speak with them at intervals to see how they are doing either by phone or through home visits as they prefer. At each follow-up study visit, the trained CHA will review and collect data on participants' clinic visits, treatment, and laboratory results.

iSTAR

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV-infected pregnant women identified during baby showers programs at participating worship centers.

You may not qualify if:

  • HIV-infected women already on treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Catholic Caritas Foundation

Makurdi, Benue State, Nigeria

RECRUITING

Related Publications (1)

  • Ezeanolue EE, Obiefune MC, Yang W, Obaro SK, Ezeanolue CO, Ogedegbe GG. Comparative effectiveness of congregation- versus clinic-based approach to prevention of mother-to-child HIV transmission: study protocol for a cluster randomized controlled trial. Implement Sci. 2013 Jun 8;8:62. doi: 10.1186/1748-5908-8-62.

    PMID: 23758933BACKGROUND

Central Study Contacts

Echezona Ezeanolue, MD, MPH

CONTACT

Chima Onoka, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Public Health and Pediatrics

Study Record Dates

First Submitted

January 6, 2017

First Posted

January 11, 2017

Study Start

July 1, 2016

Primary Completion

March 1, 2020

Study Completion

March 1, 2020

Last Updated

January 11, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will not share

Locations